Apr 18, 2024
In this episode, Dr. Shawn Tassone discusses a recent study published in the Journal of the North American Menopause Society that challenges the previous negative views on hormone replacement therapy (HRT) for women over the age of 65.
The study found that HRT, specifically estrogen therapy, beyond the age of 65 is associated with significant risk reductions in mortality, breast cancer, lung cancer, colorectal cancer, congestive heart failure, venous thromboembolism, atrial fibrillation, heart attacks, and dementia. The study also highlighted the importance of individualized hormone therapy, lower doses, and non-oral routes of administration for optimal health outcomes.
Episode Highlights
Resources
Dr. Shawn Tassone's Practice | Tassone Advanced Gynecology
Dr. Shawn Tassone's Book | The Hormone Balance Bible
Dr. Shawn Tassone's Integrative Hormonal Mapping System | Hormonal Archtype Quiz
Medical Disclaimer
This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.